Thursday, January 2, 2025 1/2/2025

Drug overdose out-of-hospital cardiac arrest events in the United States: Insights from a large data registry

Award Number: R21HL156198
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

PROJECT SUMMARY Drug overdose out-of-hospital cardiac arrest (OD-OHCA) is a serious and growing public health threat that is wholly understudied. Currently, we lack a broadly-representative, contemporary clinical profile of OD-OHCA across America and we do not know the relative societal disease burden of OD-OHCA. In addition, we do not have a direct comparison of OD-OHCA and presumed cardiac etiology (C-OHCA) controls statistically matched by age and other key clinical factors. Further, the optimal post-resuscitation treatment for OD-OHCA event survivors is unknown. Our research will address these knowledge gaps. Our central hypothesis is that there will be a substantial public health impact from OD-OHCA relative to other high-burden diseases, statistically significant and clinically important differences between OD-OHCA and propensity-matched C- OHCA outcomes, and potential therapeutic benefit to provision of targeted temperature mangement (TTM) during post-resuscitation critical care. The scientific premise for this work is that we currently do not adequately understand the full scope of OD-OHCA in America, and the Cardiac Arrest Registry to Enhance Survival (CARES) dataset is the largest collection of homogeneous, contemporary data on this cohort for analysis to fill these important knowledge gaps and accelerate the pace of drug abuse research in this area. From CARES, we will create a broadly-representative, contemporary clinical profile of OD-OHCA across America, estimate the public health impact of OD-OHCA as measured by disability-adjusted life years lost (DALY [inclusive of mortality and morbidity]), compare OD-OHCA patient outcomes to propensity-match controls with C-OHCA, and determine the effect of post-resuscitation TTM on patient outcomes as measured by hospital discharge Cerebral Performance Category (CPC) scale scores. This research is significant because currently little is known about substance use disorder from the perspective of OD-OHCA in this rapidly growing segment of society, and our findings can be translated directly into clinical care protocols and will potentially modify care guidelines to save lives. Our work is innovative in that we will be accessing an enormous, broadly-representative repository of prospectively collected and validated data from throughout the country. Further, the highly capable research team has members with priority access to the actively expanding CARES dataset for this analysis, collaborators with considerable expertise in OHCA as well as vast experience in predictive modeling using large datasets. This work will help enable high-quality research to advance scientific knowledge on this potential consequence of addiction and drug use to directly improve patient care for this stigmatized, vulnerable population.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$14,001 )
2024	2022	BAYSTATE MEDICAL CENTER, INC.	759 CHESTNUT STREET	SPRINGFIELD	MA	01199	HAMPDEN	USA	Cardiovascular Diseases Research	000	2	12/11/2023	NON-COMPETING CONTINUATION	-$14,001
														Subtotal = -$14,001

Issue Date FY: 2022 ( Subtotal = $111,000 )
2022	2022	BAYSTATE MEDICAL CENTER, INC.	759 CHESTNUT ST	SPRINGFIELD	MA	01199	HAMPDEN	USA	Cardiovascular Diseases Research	000	2	2/1/2022	NON-COMPETING CONTINUATION	$99,900
2022	2022	BAYSTATE MEDICAL CENTER, INC.	759 CHESTNUT ST	SPRINGFIELD	MA	01199	HAMPDEN	USA	Cardiovascular Diseases Research	001	2	5/31/2022	NON-COMPETING CONTINUATION	$11,100
														Subtotal = $111,000

Issue Date FY: 2021 ( Subtotal = $111,000 )
2021	2021	BAYSTATE MEDICAL CENTER, INC.	759 CHESTNUT ST	SPRINGFIELD	MA	01199	HAMPDEN	USA	Cardiovascular Diseases Research	000	1	1/29/2021	NEW	$111,000
														Subtotal = $111,000

Grand Total All Awards = $207,999

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Drug overdose out-of-hospital cardiac arrest events in the United States: Insights from a large data registry

Award Number: R21HL156198

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer